日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation.

PRMT5 的抑制通过促进异常 R 环的积累,引发 ARID1A 缺陷型子宫内膜癌的合成致死。

Shu Wan, Dong Kejun, Shen Xiaoyu, Zhou Xing, Zhang Jiarui, Yu Shuyang, Cheng Shuangshuang, Zhang Tangansu, Chen Guanxiao, Zhong Guanglei, Zhang Jun, Wang Hongbo

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma

利用 CRISPR/Cas9 技术对小鼠子宫内膜中的抑癌基因进行多重编辑,可重现高危子宫内膜癌的发生发展过程。

Vidal-Sabanés, Maria; Navaridas, Raúl; Bonifaci, Núria; Gay-Rua, Ada; Ortega-Peinado, Damià; Egea, Joaquim; Encinas, Mario; Matias-Guiu, Xavier; Llobet-Navas, David; Dolcet, Xavier

EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer.

EIF1AX 核仁凝聚体增强子宫内膜癌治疗的敏感性。

Lipid-Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial-Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial Cancer.

脂质驱动的 OLR1/FOXM1/FGF19 轴协调上皮-成纤维细胞正反馈中的串扰,促进子宫内膜癌的孕激素抵抗。

Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma.

利用干细胞工程技术生成靶向子宫内膜癌的同种异体CAR导向的自然杀伤T细胞。

Li Yan-Ruide, DiBernardo Gabriella A, Chen Yuning, Shen Xinyuan, Hon Ryan, Ruegg Lauryn E, Huang Jie, Neal Adam, Moatamed Neda A, Memarzadeh Sanaz, Yang Lili

Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathways

产生三甲胺的微生物巨大芽孢杆菌KCTC 3007通过I型干扰素反应途径促进子宫内膜癌的抗肿瘤免疫

Min, Kyungchan; Kim, Se Ik; Lee, Minji; Kim, Yunjae; Jeong, Chanyeong; Kim, Sujeong; Kim, Sang Jin; Kim, Hyun; Cho, Beomki; Joo, Yanghyun; Park, Hansoo; Lee, Maria

Non-Invasive Assessment of Complete Regression in Endometrial Cancer Patients Undergoing Fertility Preservation Using MRI-Based Radiomics and Immune Heterogeneity

利用基于MRI的放射组学和免疫异质性对接受生育力保存的子宫内膜癌患者进行无创性完全消退评估

Li, Xingchen; Shang, Kun; Wang, Jingyuan; Zhu, Aoxuan; Wu, Yuman; Qi, Yue; Bi, Xinyi; Wang, Yiqin; Wang, Jianliu

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

Biomaterial-enabled multimodal therapy for endometrial cancer: Subtype-guided immuno-metabolic modulation and fertility-conscious regeneration

生物材料赋能的多模式疗法治疗子宫内膜癌:亚型导向的免疫代谢调控和兼顾生育力的再生

Wang, Min; Wang, Cuihong; Xin, Bing; Zhao, Lijie; Cai, Benshuo; Guan, Yuheng; Lu, Lu; Zhang, Chong

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

在复发性子宫内膜癌和卵巢癌患者中应用Copanlisib和Niraparib联合治疗(COPANIRA):疗效、毒性和转化研究进展

Brodsky, Allison L; Asare, Amma; Fellman, Bryan; Anderson, Kristin; Yao, Jun; Lee, Sanghoon; Tran, Hai; Xu, Xun; Liu, Jinsong; Celestino, Joseph; Hajek, Richard A; Morgan, Margaret B; Mohammad, Mohammad; Soliman, Pamela; Shafer, Aaron; Sood, Anil K; Bodurka, Diane; Fleming, Nicole D; Onstad Grinsfelder, Michaela; Milojevic, Ljiljana; Jazaeri, Amir A; Mills, Gordon B; Coleman, Robert L; Westin, Shannon N